NCCN

NCCN B-Cell Lymphomas Guideline Features Therapy Updates in Follicular Lymphoma, DLBCL
Guideline Updates
NCCN B-Cell Lymphomas Guideline Features Therapy Updates in Follicular Lymphoma, DLBCL
07/13/2020
The National Comprehensive Cancer Network (NCCN) released an update to its guideline for B-cell lymphomas. In the section for follicular lymphoma with histologic transformation to diffuse large B-cell lymphoma...
The National Comprehensive Cancer Network (NCCN) released an update to its guideline for B-cell lymphomas. In the section for follicular lymphoma with histologic transformation to diffuse large B-cell lymphoma...
The...
07/13/2020
Journal of Clinical Pathways
NCCN Updates Clinical Practice Guideline for Thyroid Carcinomas
Guideline Updates
NCCN Updates Clinical Practice Guideline for Thyroid Carcinomas
06/22/2020
The National Comprehensive Cancer Network (NCCN) recently released an updated version of its clinical practice guideline for thyroid carcinomas. Multiple global updates are included throughout the guideline,...
The National Comprehensive Cancer Network (NCCN) recently released an updated version of its clinical practice guideline for thyroid carcinomas. Multiple global updates are included throughout the guideline,...
The...
06/22/2020
Journal of Clinical Pathways
Overview of the Updated NCCN Guidelines on Ovarian Cancer
Special Report
Overview of the Updated NCCN Guidelines on Ovarian Cancer
06/17/2020
While ovarian cancer is the second most common gynecologic cancer in the United States, behind uterine cancer,1 it is the top gynecologic cancer in mortality.2 In 2020, an estimated 21,750 new cases of ovarian cancer...
While ovarian cancer is the second most common gynecologic cancer in the United States, behind uterine cancer,1 it is the top gynecologic cancer in mortality.2 In 2020, an estimated 21,750 new cases of ovarian cancer...
While...
06/17/2020
Journal of Clinical Pathways
News
NCCN Biomarker Guideline Adherence Linked With Decreased Mortality in NSCLC
06/16/2020
Adherence to the National Comprehensive Cancer Network (NCCN) guideline for biomarker testing for non-squamous advanced non-small cell lung cancer (NSCLC) is associated with decreased risk of mortality, according to a recent...
Adherence to the National Comprehensive Cancer Network (NCCN) guideline for biomarker testing for non-squamous advanced non-small cell lung cancer (NSCLC) is associated with decreased risk of mortality, according to a recent...
Adherence to the National...
06/16/2020
Journal of Clinical Pathways
New NCCN Guidelines Advise More Physician-led Discussions of Sexual Dysfunction
04/07/2016
JCP Editors
Clinicians should take a more active role in discussing sexual dysfunction with their patients, according to updates to National Comprehensive Cancer Network (NCCN) guidelines, which were presented at the NCCN annual...
Clinicians should take a more active role in discussing sexual dysfunction with their patients, according to updates to National Comprehensive Cancer Network (NCCN) guidelines, which were presented at the NCCN annual...
...
04/07/2016
Journal of Clinical Pathways
NCCN CEO Compares Evidence Blocks With Other Tools to Assess Value of Cancer Care Treatments
04/01/2016
JCP Editors
In a session at their 21st Annual Meeting in Hollywood, FL, National Comprehensive Cancer Network (NCCN) CEO Robert W Carlson, MD, discussed how NCCN Evidence Blocks stack up against other tools currently available...
In a session at their 21st Annual Meeting in Hollywood, FL, National Comprehensive Cancer Network (NCCN) CEO Robert W Carlson, MD, discussed how NCCN Evidence Blocks stack up against other tools currently available...
In a...
04/01/2016
Journal of Clinical Pathways
Adolescent Hodgkin Lymphoma Patients Not Receiving Optimal Follow-up Care
01/18/2016
JCP Editors
Adolescent and young adult (AYAs) survivors of Hodgkin lymphoma may not be receiving the recommended post-treatment care, according to a recent study. Cancer is the leading cause of death in AYAs, and Hodgkin...
Adolescent and young adult (AYAs) survivors of Hodgkin lymphoma may not be receiving the recommended post-treatment care, according to a recent study. Cancer is the leading cause of death in AYAs, and Hodgkin...
...
01/18/2016
Journal of Clinical Pathways
Interview
Evidence Blocks to Evaluate the Relative Value of Oncology Treatments
12/14/2015
Many institutions and health care professionals have been aware of the staggering rise of health care costs. An IMS Health report published in May of 2015 confirmed that drug sales in the United States surpassed $100...
Many institutions and health care professionals have been aware of the staggering rise of health care costs. An IMS Health report published in May of 2015 confirmed that drug sales in the United States surpassed $100...
Many...
12/14/2015
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use